Singapore markets closed

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.48+1.19 (+4.53%)
At close: 04:00PM EDT
27.60 +0.12 (+0.44%)
After hours: 07:55PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-264,301
-255,099
-166,000
-58,223
-542,731
Depreciation & amortisation
46,497
43,619
33,006
28,254
19,021
Stock-based compensation
160,978
166,950
136,848
95,962
48,626
Change in working capital
17,006
17,343
-39,417
-87,445
-50,381
Accounts receivable
-13,376
-10,613
-18,948
-34,041
-17,847
Inventory
-1,617
7,871
-21,192
-30,132
-14,601
Accounts payable
-653
-6,017
5,858
11,084
-7,770
Other working capital
-73,949
-64,721
-165,267
-122,651
-256,292
Other non-cash items
-
-
-
-
306,017
Net cash provided by operating activities
-26,797
-15,197
-33,606
-21,373
-217,898
Cash flows from investing activities
Investments in property, plant and equipment
-47,152
-49,524
-131,661
-101,278
-38,394
Acquisitions, net
-
0
-4,000
-5,451
0
Purchases of investments
-
0
-282,871
0
-
Sales/maturities of investments
71,320
183,016
67,645
0
-
Net cash used for investing activities
24,168
133,492
-350,887
-106,729
-38,394
Cash flows from financing activities
Debt repayment
-
-
0
0
-31,256
Common stock issued
-
-
0
0
482,267
Other financing activities
-
-5,814
-5,409
-5,028
-5,848
Net cash used provided by (used for) financing activities
18,721
13,669
15,817
35,297
468,906
Net change in cash
15,987
131,931
-368,720
-92,571
212,151
Cash at beginning of period
339,794
227,353
596,073
688,644
476,493
Cash at end of period
355,886
359,284
227,353
596,073
688,644
Free cash flow
Operating cash flow
-26,797
-15,197
-33,606
-21,373
-217,898
Capital expenditure
-47,152
-49,524
-131,661
-101,278
-38,394
Free cash flow
-73,949
-64,721
-165,267
-122,651
-256,292